Philip Caffery
Papers
1
Total Citations
14
H-Index
1
About
Philip Caffery is a urologic surgeon and clinical researcher whose work centers on optimizing perioperative care and thromboembolism management in major urologic oncology procedures. His primary research areas include venous thromboembolism (VTE) prophylaxis, robotic surgery outcomes, and enhanced recovery pathways for patients undergoing radical cystectomy. Caffery’s most notable contribution is his 2021 retrospective feasibility study on direct oral anticoagulants (DOACs) for VTE prevention following robot-assisted radical cystectomy, which provided early evidence supporting the safety and practicality of DOACs in this high-risk population. This work, cited 14 times, has helped inform evolving protocols for thromboprophylaxis in urologic oncology, bridging a gap between hematology and surgical practice. Beyond this landmark paper, Caffery has contributed to the broader literature on robotic surgical techniques and postoperative complication reduction. His research is characterized by a pragmatic, patient-centered approach that translates directly into clinical guidelines. For students and researchers interested in the intersection of urologic surgery, anticoagulation, and quality improvement, Caffery’s work offers a clear example of how single-center feasibility studies can catalyze larger, practice-changing investigations.
Research Focus
Key Achievements
Top Papers
- 1